Theme: Trending Challenges in Non-Communicable Diseases

Non-Communicable Diseases-2016
Tentative Program

Non-Communicable Diseases-2016

Conference Series invites all the participants from all over the world to attend 'World Congress on Non Communicable Diseases and Therapies' during December 08-09, 2016 in Phoenix, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. 

Non Communicable Diseases-2016 is to  gathering people in academia and society interested in diseases to share the latest trends and important issues relevant to our field/subject area. The scientific programme of the conference is broad and embraces different research aspects of non-communicable diseases. The conference will include invited speakers, oral presentations, poster session and the young scientist award.

Track 1: Cardiovascular Diseases

Diseases of Heart or Blood vessels are called as Cardiovascular Diseases. Blood flow to the heart, brain or body can be reduced as the result of a clotting of blood i.e., thrombosis, or by a build-up of fatty deposits inside an artery that cause the artery to harden and narrow.  Cardiovascular diseases are the leading cause of death globally. There are several risk factors for heart diseases such as  age, gender, tobacco use, physical inactivity, excessive alcohol consumption, unhealthy diet, family history of any cardiovascular disease, raised blood pressure hypertension, raised blood sugar diabetes mellitus, raised blood cholesterol i.e., hyperlipidemia, psychosocial factors, poverty and low educational status, and air pollution. Evidence shows that eating and drinking habits established during childhood can continue for many years into adulthood.

Related Conferences

Cardiovascular Imaging Conference, November 10-12, 2016 Istanbul, Turkey; Arrhythmias Congress July 14-15, 2016 Brisbane, Australia; Cardio Vascular Medicine Conference April 04-06, 2016 Philadelphia, USA; Echocardiography Conference July 18-19, 2016 Berlin, Germany; 10thInterventional Cardiology Congress September 12-14, 2016 Berlin, Germany; World Congress of Cardiology and Cardiovascular Health June 04-07, 2016, Mexico City, Mexico; 19th Annual Update on Pediatric and Congenital Cardiovascular Disease  February 24-28, 2016 Orlando, USA; European Society of Cardiology Congress August 27 - 31 2016 Rome,  Italy;  International conference on Cardiology and Cardiac surgery  April 04-06, 2016, Dubai, UAE.

Track 2: Cancers

Cancer, are also known as a malignant tumor or malignant neoplasm, this is a group of diseases involving abnormal cell growth with the potential to invade and/or spread to the other parts of the body. Cancer can start anywhere in the human body which is made up of trillions of cells. Human cells grow, divide to form new cells as the body needs them in that way. When cells grow old or become damaged, they die, and new cells take their place, many cancers form solid tumors, which are the  masses of tissue. Cancers of blood, such as leukemia’s, generally do not form solid tumors. Many cancers can be prevented by avoiding smoking and maintaining a healthy weight, not drinking  much alcohol, eating plenty vegetables, fruits, whole grains, getting  vaccinated against certain infectious diseases, not eating  much processed and red meat,  avoiding  much exposure to sunlight. Systemic symptoms include unintentional weight loss, fever, excessively tired, changes to the skin. Hodgkin disease, leukemias, cancers of the liver or kidney can cause a persistent fever of unknown origin.

Related Conferences

13th Euro Global Summit on Cancer Therapy September 26-28, 2016 London, UK; 13th Global Summit on Cancer Therapy November 21-23, 2016 Dubai, UAE; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; 11th Asia-Pacific Oncologists Annual Meeting October 17-19, 2016 Kuala Lumpur, Malaysia; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; 14th World Congress on Cancer Therapy December 08-10, 2016 Baltimore, USA;  A Matter of Life or Death: Cell Death in Cancer 28–30 January 2016 Amsterdam, Netherlands; 12th International Conference of the Asian Clinical Oncology Society 8 - 10 April 2016, New Delhi, India; NCCN Annual Conference: Advancing the Standard of Cancer Care March 31 -April 2, 2016 Hollywood, Florida; 28th Lorne Cancer Conference, 11- 13 February 2016, Lorne, Australia; International Conference on Thyroid Cancer and Treatment Aug 1-3, 2016 Toronto, Canada; 2nd International Conference on Antimicrobial Agents and Chemotherapy December 08-09, 2016 San Antonio, USA; International Conference and Exhibition on Surgical Oncology August 24-26, 2016 Sao Paulo, Brazil.

Track 3: Chronic Respiratory Diseases

Chronic respiratory diseases are diseases of airways and other structures of the lung. Some of the most common are COPD, pulmonary hypertension, occupational lung diseases and asthma. Tobacco smoke is a major key factor in the development and progression respiratory diseases, including COPD although exposure to air pollutants in the home, workplace, genetic factors, and also  respiratory infections also play a role. Antibiotics and corticosteroids are used in treating patients with acute exacerbations of this disease  and clinicians choose different antibiotics and varying doses of steroids. COPD affects more men than women, however the rates in women are increasing.

Related Conferences

International Conference on Pulmonary & Respiratory Medicine October 29-31, 2012 Chicago-North Shore, USA; International Conference and Exhibition on Lung Disorders & Therapeutics July 13-15, 2015 Baltimore, Maryland, USA; 2nd International Conference on Respiratory and Pulmonary Medicine  May 09-10, 2016 Chicago, USA; 4th International Conference on Lung & Respiratory Care August 01-03, 2016 Manchester, UK ; 3rd International Workshop on Lung Health, Asthma and COPD: converging,15–17 January 2016, Monaco; 3rd Allergy, Asthma & COPD Conference, 25–26 January 2016,United States; Drug Discovery for Parasitic Diseases, 24–28 January 2016, United States; Better Breathing Conference, 29–30 January 2016, Canada; Cell Biology and Immunology of Persistent Infection, 31 January–4 February 2016,Canada; Pulmonary Medicine Western Caribbean Cruise Co-Sponsored w/School of Medicine, SUNY at Stony Brook,30 January – 6 February 2016,United States.

 

Track 4: Autoimmune Diseases

Autoimmune disorder occurs when our  body’s immune system attacks and destroys healthy body tissue by mistake. There are over  80 types of autoimmune diseases. Autoimmune diseases can affect many parts of the body. Getting a diagnosis can be frustrating and stressful. Moreover, the first symptoms are fatigue, muscle aches and a low fever. The classic signs for autoimmune disease is inflammation, which causes redness, heat, pain and swelling. Many people take medicines to reduce the immune system's abnormal response. They are called immunosuppressive medicines. Symptoms of autoimmune disorders can come and go. If  symptoms get worse, it is called a flare-up.

Related Conferences

International Conference on Autoimmunity October 13-14, 2016 Manchester, UK; 2nd International Conference on Innate Immunity, July 21-22, 2016, Berlin, Germany; International Conference on Mucosal Immunology July 28-29, 2016 Melbourne, Australia; 5th European Immunology Conference, July 21-23, 2016 Berlin, Germany; International Conference on Allergy, Asthma & Clinical Immunology September 14-15, 2016 Amsterdam, Netherlands;; International Conference on Thyroid Disorders and Treatment February 29-March 02, 2016 Philadelphia, Pennsylvania, USA;  2nd International Conference and Exhibition on Antibodies July 11-12, 2016 Philadelphia, Pennsylvania, USA.

Track 5: Chronic Kidney Diseases

Chronic kidney disease is progressive loss in kidney function over a period of months or years. You may develop complications like high blood pressure, poor nutritional health, weak bones and nerve damage. The symptoms of worsening kidney function is  not specific, and include feeling generally unwell and experiencing a reduced appetite. Chronic kidney disease may not become recognizable  until your kidney function is significantly impaired. Chronic kidney disease is diagnosed  by  blood test for creatinine, which is a breakdown product of muscle metabolism. Higher levels of creatinine show a lower glomerular filtration rate and a decreased capability of the kidneys to excrete waste products. The presence of CKD confers an increased risk of cardiovascular disease, and people with CKD usually  have other risk factors for heart disease, as high blood lipids. The most common cause of death in people with CKD is cardiovascular disease more than kidney failure.

Related Conferences

5th Global Nephrologists Annual Meeting March 31-April 02, 2016, Spain; 6th  Annual Conference on Clinical Nephrology May 9-11, 2016, USA; 7th  European Nephrology Conference November 7-9, 2016 Alicante, Spain ; Annual Meeting on Pediatric Nephrology May 9-11, 2016, USA; 9th  World Nephrology Congress August 18-20, 2016, Brazil; Australian and New Zealand Society of Nephrology 17 -21 September, 2016, Australia; Kidney Week- American Society of Nephrology 31 October - 05 November 2016, USA; American Society of Nephrology 15-20 November, 2016, USA; 53rd  European Renal Association 21-24 May,2016, Austria; Asian Pacific Society of Nephrology 17-21 September 2016, Australia.

Track 6: Diabetes

Diabetes is one of metabolic diseases in which there are high blood sugar levels over a prolonged period. Diabetes is due to pancreas not producing enough insulin or the cells of the body not responding properly to the insulin produced. Having too much glucose in your blood  causes serious problems. It can damage your eyes, nerves and kidneys. Diabetes causes heart disease, stroke and sometimes need to remove a limb. Pregnant women may also get diabetes, called gestational diabetes. All types of diabetes increase the risk of long-term complications. The complications of diabetes may include  to damage in small blood vessels, damage to the eyes, kidneys, and nerves.

Related Conferences

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA; 8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; 10th European Diabetes Congress July 14-16 2016, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015, India; Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15 19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico

Track 7: Alzheimer's disease

Alzheimer's disease is one  type of dementia that causes problems with memory, thinking and behavior. It is an irreversible, increased  brain disorder which  slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks.  Risk factors include a history of head injuries, depression, or hypertension. The causes of dementia may  vary, depending on the types of brain changes that may be taking place. As Alzheimer’s disease improves, people have memory loss and other cognitive difficulties. In the later stages of Alzheimer's disease some may become much aware of what is happening around them. They may  experience difficulties eating , walking without help, become increasingly frail.

Related Conferences

5th World Congress on Neurology and Therapeutics March 14-16, 2016, London, UK; 6th  World Neurological Conference May 19-21, 2016, San Antonio, USA; 4th International Conference on Vascular Dementia June 30 - July 02 2016, Valencia Spain; 2nd  International Conference on Brain Disorders and Therapeutics October 27-29, 2016, Chicago, USA, International Conference on Neuroimaging and Interventional Radiology June 13-15, 2016 ,Rome Italy;  Global Neuroscience Conference November 07-09 2016 Melbourne, Australia; 31st Alzheimer’s Disease International, April 20 – 24 2016 Budapest, UK; 10th Frontotemporal Dementias Conference Aug 31- Sep 2 2016, Munich, Germany; Alzheimer's Conference July 23-28 2016 Toronto, Canada; 18th Alzheimer  Conference March 1-2 2016 Miami USA.

Track 8: Osteoporosis

Osteoporosis is a disease of bones. It happens when you lose too much bone, make too little bone or both. Risk factors for osteoporosis involve aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Osteoporosis may be usually due to lower than normal peak bone mass and greater than normal bone loss. Generally bone loss increases after menopause because of  lower levels of estrogen. Bone fractures, particularly in the spine or hip, which are the most serious complication for osteoporosis. Hip fractures can  result from a fall and can result in disability and sometimes death from postoperative complications, especially in older people. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications.

Related Conferences

7th Global Orthopedicians Annual Meeting October 20-22; 4th International Conference on Orthopedics & Rheumatology October 26-28, 2015, USA; Global Summit and Medicare Expo on Head & Neck Surgery, November 30-December 01, 2015, USA; 4th International Conference and Exhibition on Surgery October 05-07, 2015, UAE; International Conference on Medical Devices September 21-22, 2015, USA; Annual European Congress of Rheumatology, London, UK; 18th Asia Pacific League of Associations for Rheumatology Congress (APLAR) 2016, Shanghai, China; 17th International Conference on Behcet’s Disease, Melbourne, Australia; 10th European Lupus Meeting 2016,Venice Italy; Fourth Systemic Sclerosis World Congress,  Alberta, Canada.

Track 9: Cataract

A cataract is  clouding of  lens in the eye leading to a decrease in vision.  Most cataracts are related to aging. Cataracts are very common in older people. Poor vision may also result in an increased risk of falling and depression. Risk factors may include diabetes, smoking, prolonged exposure to sunlight, and alcohol. Other factors that can increases risk of developing cataracts because of cigarette smoke, air pollution, and heavy alcohol consumption. Prevention by wearing sunglasses and avoiding smoking. Early on the symptoms may be improved with eyeglasses. If this does not help, surgery has to done to  remove the cloudy lens and replace it with an artificial lens is the only effective treatment.

Related Conferences

7th European Ophthalmology Conferences, June 16-18, 2016 Spain;6th Global Ophthalmologists Annual Meeting, May 16-18, 2016, Japan; 10th International Conference on Clinical & Experimental Ophthalmology, November 21-23, 2016, UAE; 2nd International Conference on Eye and Vision, September 26-28, 2016, USA; 8th Global Ophthalmology Meeting, July 18-20, 2016, USA; Australasian Society of Cataract and Refractive Surgeons; 19th Annual Conference 2015 (AUSCRS 2015),October 07-10,2015  Noosa Heads, Australia; European Association for Vision and Eye Research Annual Meeting, October 07-10,2015 Nice, France; United Kingdom And Ireland Society Of Cataract And Refractive Surgeons; 39th Annual Meeting 2015 (UKISCRS 2015), October 22-23,2015 Hinckley, United Kingdom; East West Eye Conference, October 01-04,2015 Cleveland, USA; The Eye Health Conference, September 28,2015 London, U.K.

Track 10: Obesity

Obesity is a where a person has accumulated so much body fat that it might have a negative effect on their health. It generally increases the risk of diseases and health problems, such as heart disease, diabetes and high blood pressure. Obesity occurs extra time when you eat more calories than you use. The balance between calories-in and calories-out differs for each person. Obesity usually results from a combination of causes and contributing factors such as Genetics, family lifestyle, no physical activity, unhealthy diet, medical problems, age, pregnancy, quitting smoking and lack of sleep.

Related Conferences

International Conference on Childhood Obesity, August 29-30, 2016 Atlanta, USA; World Congress on Obesity August 08-10, 2016 Toronto, Canada; 3rd Global Experts Meeting on Weight Loss and Medical Expo, Vienna, Austria; International Conference on Weight Loss and Fitness Expo  November 21-23, 2016 Dubai, UAE; 8th Euro Obesity & Endocrinology Specialists Annual Meeting, October 10-12, 2016 Manchester, UK; International Conference on Obesity Vancouver Canada; The 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension Istanbul, Turkey; ASO UK Congress on Obesity, Glasgow, Scotland; Overcoming Obesity Diagnose, Personalize, Treat, Washington, USA; Central European Congress on Obesity, Budapest, Hungary; Obesity Week 2016 October 31–November 5, 2016 Louisiana, USA; The 6th Conference on Recent   Advances  in the Prevention and Treatment of Childhood and Adolescent Obesity   Oct 24 -26, 2016 Ottawa, Canada; 5th Annual Middle East Congress on Clinical Nutrition March 22-24, 2016 Cairo, Egypt

 

Conference Series invites all the participants from all over the world to attend “World Congress on Non Communicable Diseases and Therapies” during December 08-09, 2016 in Phoenix, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. 

Non Communicable Diseases 2016 is to  gathering people in academia and society interested in diseases to share the latest trends and important issues relevant to our field/subject area. The scientific programme of the conference is broad and embraces different research aspects  and medical interest. The conference will include invited speakers, oral presentations, poster session and the young scientist award. Conference Series organizes a series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Why to attend??

With members from around the world focused on learning about non communicable diseases and its advances; this is your best opportunity to reach the largest assemblage of participants from the community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in non-communicable diseases are hallmarks of this conference.


Target Audience

  • Cardiologists
  • Oncologists
  • Diabetologists
  • Neurologists
  • Nephrologists
  • Scientists
  • Students
  • Researchers
  • Faculty
  • Medical Colleges
  • Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Manufacturing Medical Devices Companies

Noncommunicable diseases (NCDs) are the leading cause of death in the WHO South-East Asia Region. Each year, an estimated 7.9 million lives are lost due to NCDs, accounting for 55% of all deaths . Furthermore, NCDs claim lives at a younger age in the South-East Asia Region compared to the other WHO regions. In 2008, the proportion of NCD deaths occurring among people under the age of 60 was 34%, compared to 23% in the rest of the world. Cardiovascular diseases are the most frequent cause of NCD deaths, followed by chronic respiratory diseases, cancers, and diabetes

In addition to the four main NCDs, many other chronic conditions and diseases contribute significantly to the NCD burden in the Region, such as renal, endocrinal, mental, neurological, haematological, gastroenterological, hepatic, musculoskeletal, skin and genetic disorders, as well as oral diseases including dental caries, periodontal diseases and oral cancers. Thalassaemia is also a serious health problem in some Member States, especially in the Maldives where approximately 18% of the population carries the Beta thalassaemia trait.

The increasing burden of NCDs is attributed to determinants such as population ageing, rapid and unplanned urbanization, negative effects of globalization (such as trade and irresponsible marketing of unhealthy products), low literacy, and poverty (Figure 2). From 2000 to 2025, it is projected that the proportion of the population aged above 65 years will increase from 3.6% to 6.6% in Bangladesh, from 4.4% to 7.7% in India and from 6.3% to 12.3% in Sri Lanka. As the prevalence of NCDs increases with age, these progressively aging populations will result in a corresponding increase in NCD cases.

  • Roughly 80 percent of NCD related deaths occur in low- and middle-income countries, where fragile health systems often struggle to meet the population’s most basic health needs.
  • WHO estimates that 48 percent of NCD deaths in low- and middle-income countries occur before 70 years old, compared with 26 percent in high income countries.
  • In 2012, all United Nations member countries committed to achieving a 25 percent reduction in premature mortality from NCDs by 2025 (the 25 x 25 target).

I am pleased to announce the “World Congress on Non Communicable Diseases” (Non Communicable Diseases -2016) to be held in Phoenix, USA, December 08-09, 2016, with the Conferenceseries as conference Organizer.

The theme of Non Communicable Diseases -2016, will be “Trending Challenges in Non-Communicable Diseases”. This annual Non Communicable Diseases conference, which for the first time is being held in USA, will bring together Oncologists, Cardiologists, Rheumatologists, nephrologists, dermatologists, neurologists, immunologists, internists, psychiatrists, radiologists and health professionals and industry representatives from around the world, providing them with the opportunity to report and discuss important scientific challenges and achievements in the field. Most importantly it will provide great opportunities for creation of new collaborations and linkages between academics, clinicians and industry. Such partnerships will be critical to translation of recent laboratory break through. Examples of the diverse topics that will be covered in this comprehensive conference include; Cardiovascular Diseases, Cancers, Chronic Respiratory diseases, Autoimmune Diseases, Chronic Kidney diseases, Diabetes, Alzheimer’s disease, Osteoporosis, Cataract, Obesity, Hypertension, Epilepsy, Genetic Diseases, Environmental Diseases. Through attendance at Non Communicable Diseases -2016, you will be able to share your research results with your colleagues and have opportunities to establish new academic and industry collaborations. Please consider joining us in Phoenix USA for an exciting Non Communicable Diseases meeting.

Dr. PeterL. Nara
CEO/President
Biological Mimetics, Inc.
Frederick, MD. 21702 USA

 

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 08-09, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View

Media Partners